Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity. - Wikidata - wikimedia - TriplyDB

Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity.

Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity.

http://www.wikidata.org/entity/Q36147611

about

Kallikrein-kinin in stem cell therapy Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice.Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis.Period2 deficiency blunts hypoxia-induced mobilization and function of endothelial progenitor cells.Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells.Particle Radiation-Induced Nontargeted Effects in Bone-Marrow-Derived Endothelial Progenitor Cells.Synergistic effect of a tissue kallikrein 1 and tissue inhibitor of matrix metalloproteinase 1 co‑expression vector on the proliferation of rat vascular smooth muscle cells.Bradykinin inhibits oxidative stress-induced senescence of endothelial progenitor cells through the B2R/AKT/RB and B2R/EGFR/RB signal pathways.Endothelial cells overexpressing IL-8 receptor reduce cardiac remodeling and dysfunction following myocardial infarction.The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).

P2860

Q27010386-B8C9586A-BB2E-4935-B409-6F823C683871 Q33698175-9DE1D358-388C-4177-9836-4D9F1D7704C0 Q33732799-B4BB34EE-9135-4179-B781-64D5ACCBE456 Q34277673-32DE1504-04F9-4FAC-934E-7F94AE6DB880 Q35070827-98BBD47D-3D87-4341-A6EA-F7895B6B3230 Q35620925-1E69788B-38B4-4B71-AFCD-B10A2B9CB310 Q36089841-5196FEF1-64C2-4BDD-B70F-66FB65E6F3EB Q36413009-E43FF9A9-7D9E-43F4-BD84-638D3E310B7F Q37476523-25EA6A4C-569B-48F6-AFD9-077658881EDC Q38597515-D89D71DB-E017-4020-A1F0-8B813FC53652 Q47554530-1D20E9C7-D31B-4288-ACCA-30E0CC80A4E5

P2860

Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity.

http://www.wikidata.org/entity/Q36147611

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Tissue kallikrein promotes car ...... itor cell functional capacity.

@ast

Tissue kallikrein promotes car ...... itor cell functional capacity.

@en

type

label

Tissue kallikrein promotes car ...... itor cell functional capacity.

@ast

Tissue kallikrein promotes car ...... itor cell functional capacity.

@en

prefLabel

Tissue kallikrein promotes car ...... itor cell functional capacity.

@ast

Tissue kallikrein promotes car ...... itor cell functional capacity.

@en

P1433

Q36147611-984E901A-B7BA-4D84-A6BF-EACDEFEE79C0

P1476

Q36147611-631D8D0D-2887-4C11-AE46-CE2EB0DE82A9

P2093

Q36147611-248E04BB-A8C2-47B1-AA0D-8A84BB4BBCAD

Q36147611-29DBFF07-6480-44A5-9DD8-EEBA2D14E73B

Q36147611-331213B3-0715-4B16-9DC9-0939512010F4

Q36147611-3676903D-0B64-4D3A-BD69-124DB093BDBB

Q36147611-4E667E1B-84CA-4F22-86C1-9B6450C559B2

Q36147611-7E839C90-F96E-45DA-A8CF-747D16A460D6

Q36147611-AB54D9AB-F03B-445C-8FC1-452E30113E5F

Q36147611-DC093D63-0181-4177-8408-91C71C9819F0

Q36147611-E76494FF-744B-43AB-B7EF-4D12B569EE3B

Q36147611-F0EAD30E-432C-4956-A5E0-E44FD1F22D8E

P2860

Q36147611-1841E0BE-1D6F-4A6D-888C-938DB24355B1

Q36147611-2135CB99-F166-47B6-A698-A8316F2FFF9E

Q36147611-2E4CA611-AD8B-4907-91AE-B85685CA37FE

Q36147611-3683494B-A768-453A-AF4B-A00D4725DC70

Q36147611-399DE24A-F2F7-4516-9DF4-BF78FDDDCB0C

Q36147611-3FEB43DC-B088-41AD-86DA-80EEFAA66218

Q36147611-4027BCE3-AFD5-4C67-BEBA-2F3F2E65377B

Q36147611-4A7B1ACC-25C7-45D0-A909-B0C9C39CACB7

Q36147611-5A730383-E826-433A-9240-F600CF2ED949

Q36147611-5BE3CD17-C89D-47C3-B2D2-FE650A087A4E

P304

Q36147611-6FE7C070-6AAB-40A2-ADCD-A774AEF2EB4D

P31

Q36147611-76CE8159-F2F6-4ADE-B4EA-6B2F7351F111

P356

Q36147611-6CE1DEE1-668B-4E42-B03F-E4B90FBA7B2D

P433

Q36147611-4D462378-9ADB-491E-823A-F3C77343FA6E

P478

Q36147611-BCBE2112-D3CE-4C07-A8B3-880FDFB0D170

P577

Q36147611-3FB429E9-29AA-41F5-AE2B-04923F8D51EA

P5875

Q36147611-16FB9F01-4FCC-496B-AEF4-63E50E3ACA3B

P698

Q36147611-F6600DEA-3606-4799-921C-6B310D1B7DF6

P921

Q36147611-0EA005C5-2A80-4CF4-9C48-83F86F3C8AA8

Q36147611-1E154FF2-2659-4F27-A49E-F93CFFA6A63D

Q36147611-5AE2EDD4-FBBD-4CD1-85F0-612DA63AE215

P932

Q36147611-34DAD10D-E747-4643-BD93-A82F182127EC

P356

P1433

Human Gene Therapy

P1476

Tissue kallikrein promotes car ...... itor cell functional capacity.

@en

P2093

Cong Fu

http://www.w3.org/2001/XMLSchema#string

Fengdi Yan

http://www.w3.org/2001/XMLSchema#string

Genshan Ma

http://www.w3.org/2001/XMLSchema#string

Julie Chao

http://www.w3.org/2001/XMLSchema#string

Lee Chao

http://www.w3.org/2001/XMLSchema#string

Naifeng Liu

http://www.w3.org/2001/XMLSchema#string

Yefei Li

http://www.w3.org/2001/XMLSchema#string

Yongjun Li

http://www.w3.org/2001/XMLSchema#string

Yuyu Yao

http://www.w3.org/2001/XMLSchema#string

Zulong Sheng

http://www.w3.org/2001/XMLSchema#string

P2860

Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4

Vascular-specific growth factors and blood vessel formation

Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle.

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential.

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.

Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction.

Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells.

Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling.

Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway

P304

859-870

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2011.123

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221902562

http://www.w3.org/2001/XMLSchema#string

P698

22435954

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

P932

3413919

http://www.w3.org/2001/XMLSchema#string